Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers.
At least two people have died, thousands of U.S. flights have been canceled and more than 1 million have lost power as destructively strong storms move through the eastern U.S.
